Back to Search Start Over

Physicians' guideline adherence is associated with long-term heart failure mortality in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry

Authors :
Ingrid Hopper
Vasilica Enache
Arintaya Phrommintikul
Lars Kober
Olga Koshelskaya
Asri Said
Juan Francisco Delgado Jiménez
Ruslan Abdullayev
Jonathan Howlett
Attila Frigy
Yury Grinshtein
Sholpan Zhangelova
Oleg Shtegman
Endre Zima
Elena Kosmacheva
Caroline Daly
Sofian Johar
Ruxandra Christodorescu
Kuan Leong Yew
Nathan Dwyer
Sergey Yakushin
Catalin Adrian Buzea
Martin Cowie
Dulce Brito
Albert Galyavich
Gulnara Junusbekova
Sergei Shalaev
Inna Viktorova
Alexandru Nechita
LUIGI TAVAZZI
Wanwarang Wongcharoen
ADISAI BUAKHAMSRI
Joanna Plonka
Svetlana Boldueva
Piotr Ponikowski
Ruslan Najafov
Alexander Kastanayan
Niall Mahon
Dmitry Zateyshchikov
Yury Vasyuk
George Giannakoulas
Ewa Lewicka
Source :
Komajda, M, Schöpe, J, Wagenpfeil, S, Tavazzi, L, Böhm, M, Ponikowski, P, Anker, S D, Filippatos, G S, Cowie, M R & QUALIFY Investigators 2019, ' Physicians' guideline adherence is associated with long-term heart failure mortality in outpatients with heart failure with reduced ejection fraction : the QUALIFY international registry ', European Journal of Heart Failure, vol. 21, no. 7, pp. 921-929 . https://doi.org/10.1002/ejhf.1459
Publication Year :
2018

Abstract

Background Physicians’ adherence to guideline-recommended therapy is associated with short-term clinical outcomes in heart failure (HF) with reduced ejection fraction (HFrEF). However, its impact on longer-term outcomes is poorly documented. In this analysis we assessed the longer-term association of physicians’ adherence with clinical outcomes, including mortality and unplanned hospitalisations, at 18-month follow-up of the QUALIFY registry (Clinical trial registration ISRCTN87465420) Method and results Data at 18 months were available for 6118 ambulatory HFrEF patients from this international prospective observational survey. Adherence was measured as a continuous variable, ranging from 0 to 1, and was assessed with regard to five classes of recommended HF medications and dosages. Most deaths were cardiovascular (CV) (228/394) and HF-related (191/394) and the same was true for unplanned hospitalisations (1175 CV and 861 HF-related hospitalisations, out of a total of 1541). According to univariable analysis, CV and HF deaths were significantly associated with physician adherence to guidelines. In multivariable analysis, HF death was associated with adherence level [subdistribution hazard ratio (SHR) 0.93, 95% confidence interval (CI) 0.87–0.99 per 0.1 unit adherence level increase; P = 0.034] as was composite of HF hospitalisation or CV death (SHR 0.97, 95% CI 0.94–0.99 per 0.1 unit adherence level increase; P = 0.043), whereas unplanned all-cause, CV or HF hospitalisations were not (all-cause: SHR 0.99, 95% CI 0.9–1.02; CV: SHR 0.98, 95% CI 0.96–1.01; and HF: SHR 0.99, 95% CI 0.96–1.02 per 0.1 unit change in adherence score; P = 0.52, P = 0.2, and P = 0.4, respectively). Conclusion These results suggest that physicians’ adherence to guideline-recommended HF therapies is associated with improved outcomes in HFrEF. Practical strategies should be established to improve physicians’ adherence to guidelines.

Details

ISSN :
18790844
Volume :
21
Issue :
7
Database :
OpenAIRE
Journal :
European journal of heart failure
Accession number :
edsair.doi.dedup.....3a8584353e5f6600a517294bd4520dc0